Medication adherence and QOL in patients with Diabetic peripheral Neuropathy
Not Applicable
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2021/07/034642
- Lead Sponsor
- not applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consenting adult patients with Type2 Diabetes according to the ADA criteria having Diabetic Peripheral Neuropathy
Exclusion Criteria
Patients who are critically ill
- Patients with cognitive impairment
- Patients who refuse for follow up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the rates of adherence to Diabetic Peripheral Neuropathy medicationsTimepoint: 3 months from the baseline
- Secondary Outcome Measures
Name Time Method 1.Determine the factors associated with Non-Adherence <br/ ><br>2. Compare the quality of life between adherent and non-adherent group of patients at 3 months. <br/ ><br>3. Study the pattern of drug use in Diabetic Peripheral NeuropathyTimepoint: 0 and 3 months